REQUEST A DEMO
Total
USD $0.00
Search more companies

Daewoong Bio Inc. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Daewoong Bio Inc. Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Daewoong Bio Inc. is an enterprise based in South Korea. Its main office is in Hwaseong. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on April 01, 2009. It currently has a total number of 364 (2023) employees. From the latest financial highlights, Daewoong Bio Inc. reported a net sales revenue increase of 20.36% in 2022. During that time, Daewoong Bio Inc.’s total assets grew by 16.12%. In, 2022, the company’s net profit margin increased by 1.38%.

Headquarters
35-9, Jeyakgongdan 4-gil Hyangnam-eup Hwaseong-si Gyeonggi
Hwaseong; Gyeonggi; Postal Code: 445937

Contact Details: Purchase the Daewoong Bio Inc. report to view the information.

Website: http://www.daewoongbio.co.kr

Basic Information
Total Employees:
Purchase the Daewoong Bio Inc. report to view the information.
Outstanding Shares:
Purchase the Daewoong Bio Inc. report to view the information.
Registered Capital:
Purchase the Daewoong Bio Inc. report to view the information.
Incorporation Date:
April 01, 2009
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Daewoong Co.,Ltd.
Company Performance
Financial values in the chart are available after Daewoong Bio Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
20.36%
Total operating revenue
20.36%
Operating profit (EBIT)
19.89%
EBITDA
18.55%
Net Profit (Loss) for the Period
30.3%
Total assets
16.12%
Total equity
13.87%
Operating Profit Margin (ROS)
-0.08%
Net Profit Margin
1.38%
Return on Equity (ROE)
2.93%
Debt to Equity Ratio
-0.1%
Quick Ratio
-0.31%
Cash Ratio
0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?